303 related articles for article (PubMed ID: 32946368)
1. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland.
Widmer AF; Frei R; Kuijper EJ; Wilcox MH; Schindler R; Spaniol V; Goldenberger D; Egli A; Tschudin-Sutter S
Emerg Infect Dis; 2020 Oct; 26(10):2370-2377. PubMed ID: 32946368
[TBL] [Abstract][Full Text] [Related]
2. Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in
Skinner AM; Yu B; Cheknis A; Pacheco SM; Gerding DN; Johnson S
Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1148-1153. PubMed ID: 32576334
[TBL] [Abstract][Full Text] [Related]
3. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
[TBL] [Abstract][Full Text] [Related]
4. Changes in the Association Between Diagnostic Testing Method, Polymerase Chain Reaction Ribotype, and Clinical Outcomes From Clostridioides difficile Infection: One Institution's Experience.
Menon A; Perry DA; Motyka J; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
Clin Infect Dis; 2021 Nov; 73(9):e2883-e2889. PubMed ID: 32930705
[TBL] [Abstract][Full Text] [Related]
5. Clostridioides difficile Infection in Cancer and Immunocompromised Patients: Relevance of a Two-step Diagnostic Algorithm and Infecting Ribotypes on Clinical Outcomes.
Yepez Guevara EA; Aitken SL; Olvera AV; Carlin L; Fernandes KE; Bhatti MM; Garey KW; Adachi J; Okhuysen PC
Clin Infect Dis; 2021 May; 72(10):e460-e465. PubMed ID: 32803229
[TBL] [Abstract][Full Text] [Related]
6. Discordant
Lenggenhager L; Zanella MC; Poncet A; Kaiser L; Schrenzel J
BMJ Open; 2020 Sep; 10(9):e036342. PubMed ID: 32928850
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
8. A Multicenter Study of the Revogene C. difficile System for Detection of the Toxin B Gene from Unformed Stool Specimens.
Mashock MJ; Faron ML; Carroll KC; Dang C; Lewis S; Salimnia H; Lephart P; Loo VG; Schmitt BH; Young S; Buchan BW; Ledeboer NA
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776191
[No Abstract] [Full Text] [Related]
9. Characteristics and outcomes of
Crone AS; Wright LM; Cheknis A; Johnson S; Pacheco SM; Skinner AM
Infect Control Hosp Epidemiol; 2024 Jan; 45(1):57-62. PubMed ID: 37462099
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a newly developed high-speed polymerase chain reaction analysis system for the diagnosis of Clostridioides difficile infection.
Furukawa K; Mitsutake H; Aso R; Sekizawa R; Okanda T; Hayashi K; Matsumoto T; Nakamura S
J Infect Chemother; 2021 May; 27(5):715-721. PubMed ID: 33402305
[TBL] [Abstract][Full Text] [Related]
11. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
Cook PP; Nichols S; Coogan M; Opera J; DeHart M
Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of toxigenic Clostridioides difficile isolates from hospitalized patients and the hospital environment in Dhaka, Bangladesh.
Sofjan AK; Islam MA; Halder K; Kabir ND; Saleh AA; Miranda J; Lancaster C; Begum K; Alam MJ; Garey KW
Anaerobe; 2020 Feb; 61():102081. PubMed ID: 31356958
[TBL] [Abstract][Full Text] [Related]
13. Performance of laboratory tests for detection for Clostridioides difficile: A multicenter prospective study in Japan.
Senoh M; Kato H; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
Anaerobe; 2019 Dec; 60():102107. PubMed ID: 31647977
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
[TBL] [Abstract][Full Text] [Related]
15. Diagnosing Clostridioides difficile infections with molecular diagnostics: multicenter evaluation of revogene C. difficile assay.
Sambri V; Gateau C; Zannoli S; Dirani G; Couturier J; Op den Buijs I; Roymans R; Hallet E; Arnold M; Zumoberhaus A; Steiner S; van de Bovenkamp J; Altwegg M; Berlinger L; Barbut F;
Eur J Clin Microbiol Infect Dis; 2020 Jun; 39(6):1169-1175. PubMed ID: 32062723
[TBL] [Abstract][Full Text] [Related]
16. Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?
Theiss AM; Balla A; Ross A; Francis D; Wojewoda C
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743303
[No Abstract] [Full Text] [Related]
17. Impact of a multipronged approach to reduce the incidence of Clostridioides difficile infections in hospitalized patients.
Katzman M; Cohrs AC; Hnatuck PE; Greene WH; Reed SM; Ward MA; Glasser FD; Loser MF; Hale CM
Am J Infect Control; 2023 Jun; 51(6):668-674. PubMed ID: 36075295
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Multidrug-Resistant
Mutai WC; Mureithi MW; Anzala O; Revathi G; Kullin B; Burugu M; Kyany'a C; Odoyo E; Otieno P; Musila L
Front Cell Infect Microbiol; 2020; 10():604986. PubMed ID: 33628744
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Clostridioides difficile Infection-Related Complications and Treatment Patterns among Nucleic Acid Amplification Test-Positive/Toxin Enzyme Immunoassay-Negative Patients.
Miller R; Morillas JA; Brizendine KD; Fraser TG
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896665
[TBL] [Abstract][Full Text] [Related]
20. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
Mah R; Locher K; Steiner TS; Stefanovic A
Anaerobe; 2023 Aug; 82():102755. PubMed ID: 37406762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
